Literature DB >> 7272893

Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas.

R D Lindberg, R G Martin, M M Romsdahl, H T Barkley.   

Abstract

From January 1963 through December 1977, 300 adults with soft-tissue sarcomas were treated by a conservative surgical excision and postoperative radiotherapy. The absolute two- and five-year disease-free survival rates are 74% (222/300) and 61.3% (103/168), respectively. The five-year survival rate varies with: (1) anatomic site, e.g., 69.4% (75/108) for extremity lesions vs. 33% (5/15) for abdominal lesions; (2) histopathologic diagnosis, e.g., 86.4% (19/22) for fibrosarcoma vs. 50% (15/30) for neurofibrosarcoma; and (3) stage of the lesion. The overall local recurrence rate was 22.3% (67/300) and 27% (81/300) of the patients developed distant metastases. The incidence of lymph node metastases as an initial site of spread was only 2.7% (8/300); therefore, elective treatment of the regional lymphatics is not indicated. The 6.5% incidence of significant complications in extremities is low and might be further diminished by careful treatment planning. The combination of conservative surgery and postoperative radiation therapy maintains a functional limb in 84.5% (169/200) of patients with extremity lesions. This rate is comparable to the five-year survival rate attained with radical surgery.

Entities:  

Mesh:

Year:  1981        PMID: 7272893     DOI: 10.1002/1097-0142(19810515)47:10<2391::aid-cncr2820471012>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  76 in total

1.  Multifactorial analysis of survival in primary extremity liposarcoma.

Authors:  H R Chang; J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Epithelioid sarcoma: a review and update.

Authors:  Joseph F Sobanko; Lindsay Meijer; Thomas P Nigra
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

3.  Local recurrence and survival in soft-tissue sarcomas.

Authors:  C P Karakousis; C Proimakis; U Rao; A F Velez; D L Driscoll
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

Review 4.  Preoperative therapy for extremity soft tissue sarcomas.

Authors:  Lara E Davis; Christopher W Ryan
Journal:  Curr Treat Options Oncol       Date:  2015-06

5.  Compartmental resection for subfascial extremity soft tissue sarcoma and quality of life in long-term survivors.

Authors:  Matthias Peiper; Hanno Matthaei; Edwin Bölke; David Zurakowski; Klaus Orth; Antje Heinecke; Wolfram Trudo Knoefel
Journal:  Wien Klin Wochenschr       Date:  2011-07-12       Impact factor: 1.704

6.  Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.

Authors:  Nicole J Look Hong; Francis J Hornicek; David C Harmon; Edwin Choy; Yen-Lin Chen; Sam S Yoon; G Petur Nielsen; Jackie Szymonifka; Beow Y Yeap; Thomas F DeLaney; John T Mullen
Journal:  Eur J Cancer       Date:  2012-10-22       Impact factor: 9.162

7.  An unusual cause of chest pain:case report.

Authors:  Ashok Subramanian; Hilary Birch; Adam Stacey-Clear
Journal:  Int Semin Surg Oncol       Date:  2007-05-03

8.  Management dilemma of a recurrent huge fibrosarcoma in a 25-year-old African: a case report.

Authors:  Ismaila A Adigun; Kolawole O Ogundipe; Jibril O Bello
Journal:  J Med Case Rep       Date:  2009-06-11

9.  Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma.

Authors:  Matthew J Krasin; Andrew M Davidoff; Xiaoping Xiong; Shengjie Wu; Chia-Ho Hua; Fariba Navid; Carlos Rodriguez-Galindo; Bhaskar N Rao; Kelly A Hoth; Michael D Neel; Thomas E Merchant; Larry E Kun; Sheri L Spunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-20       Impact factor: 7.038

10.  Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.

Authors:  Samuel Aguiar Junior; Fábio de Oliveira Ferreira; Benedito Mauro Rossi; Erika Maria Monteiro Santos; João Victor Salvajoli; Ademar Lopes
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.